Sanofi’s plans to submit itepekimab to regulators for approval this year have been thrown into doubt after the ...

The FDA has slapped a clinical hold on Rocket Pharmaceuticals’ pivotal gene therapy trial in response to a death. Rocket, ...

Nice 23andMe sale hearing ya got there — shame if something happened to it, say attorneys for co-founder and former CEO who ...

Shares Biotechnology ETF offers efficient, diversified exposure to the sector's revival, balancing risk and cost for ...

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know from its history.

Michael Yee, Jefferies senior biotech analyst, joins CNBC's 'Squawk on the Street' to discuss how AI could fuel drug ...

Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously iterating that low ...

The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Biotech stocks lagged the broader market in ... and spending plans and make the best decisions for your timeline and risk tolerance. Before you make your next trade, you'll want to hear this.

The Polar report also examines growth drivers, including the dynamic food and beverage industry, stringent food safety ...